AAAAAA
Results:
1-7
|
Results: 7
Authors:
ENDRIKAT J
MULLER U
DUSTERBERG B
Citation: J. Endrikat et al., A 12-MONTH COMPARATIVE CLINICAL INVESTIGATION OF 2 LOW-DOSE ORAL-CONTRACEPTIVES CONTAINING 20-MU-G ETHINYLESTRADIOL 75-MU-G GESTODENE AND 30-MU-G ETHINYLESTRADIOL 75-MU-G GESTODENE, WITH RESPECT TO EFFICACY, CYCLE CONTROL, AND TOLERANCE, Contraception, 55(3), 1997, pp. 131-137
Authors:
DUSTERBERG B
ELLMAN H
MULLER U
ROWE E
MUHE B
Citation: B. Dusterberg et al., A 3-YEAR CLINICAL INVESTIGATION INTO EFFICACY, CYCLE CONTROL AND TOLERABILITY OF A NEW LOW-DOSE MONOPHASIC ORAL-CONTRACEPTIVE CONTAINING GESTODENE, Gynecological endocrinology, 10(1), 1996, pp. 33-39
Authors:
SPONA J
ELSTEIN M
FEICHTINGER W
SULLIVAN H
LUDICKE F
MULLER U
DUSTERBERG B
Citation: J. Spona et al., SHORTER PILL-FREE INTERVAL IN COMBINED ORAL-CONTRACEPTIVES DECREASES FOLLICULAR DEVELOPMENT, Contraception, 54(2), 1996, pp. 71-77
Authors:
WINKLER UH
SCHINDLER AE
ENDRIKAT J
DUSTERBERG B
Citation: Uh. Winkler et al., A COMPARATIVE-STUDY OF THE EFFECTS OF THE HEMOSTATIC SYSTEM OF 2 MONOPHASIC GESTODENE ORAL-CONTRACEPTIVES CONTAINING 20 MU-G AND 30 MU-G ETHINYLESTRADIOL, Contraception, 53(2), 1996, pp. 75-84
Authors:
GROSS U
HONCAMP M
DAUME E
FRANK M
DUSTERBERG B
DOSS MO
Citation: U. Gross et al., HORMONAL ORAL-CONTRACEPTIVES, URINARY PORPHYRIN EXCRETION AND PORPHYRIAS, Hormone and Metabolic Research, 27(8), 1995, pp. 379-383
Authors:
ENDRIKAT J
JAQUES MA
MAYERHOFER M
PELISSIER C
MULLER U
DUSTERBERG B
Citation: J. Endrikat et al., A 12-MONTH COMPARATIVE CLINICAL INVESTIGATION OF 2 LOW-DOSE ORAL-CONTRACEPTIVES CONTAINING 20-MU-G ETHINYLESTRADIOL 75-MU-G CESTODENE AND 20-MU-G ETHINYLESTRADIOL 75-MU-G DESOGESTREL, WITH RESPECT TO EFFICACY,CYCLE CONTROL AND TOLERANCE, Contraception, 52(4), 1995, pp. 229-235
Authors:
FUCHS N
DUSTERBERG B
WEBERDIEHL F
MUHE B
Citation: N. Fuchs et al., THE EFFECT ON BLOOD-PRESSURE OF A MONOPHASIC ORAL-CONTRACEPTIVE CONTAINING ETHINYLESTRADIOL AND GESTODENE, Contraception, 51(6), 1995, pp. 335-339
Risultati:
1-7
|